ESR Analyzers is a device used to analyze the erythrocyte sedimentation rate.
Global consumption of ESR Analyzers is about 54000 units in 2018 and is projected to reach 77550 units by 2024, at a CAGR of 6.22% during the forecast period.
The future of the global ESR analyzers market is attractive with opportunities in end use application segments, including hospital, university, research institution and others. The global ESR analyzers market is expected to reach an estimated $341.20 Million by 2022 and it is forecast to grow at a CAGR of 5.78% from 2017 to 2022. The major drivers for growth in this market are increasing demand for health.
Within the global ESR Analyzers market, the hospital segment is expected to remain the largest market in terms of value and volume consumption. The major driver for this segment are rapid increasing of People are paying more and more attention to health.
The global market for medical devices was estimated to reach $361 billion dollars by year's end. With 3% average growth, the health care market researcher expects that the market should grow to $427 billion in 2018.
Because of the variety of types of medical devices, there are many competitors. Still eighteen companies earn most of the global revenue in the device market. Most companies operate in just a few markets, though the top companies such as J&J, GE Healthcare, Siemens, and Medtronic are multi-billion-dollar companies that operate in several categories.
The key customer of medical devices is hospitals, and so to some degree their success will determine the success of the device market.
Key players in global ESR Analyzer market include: Diesse, RR Mechatronics, Alifax, Vital Diagnostics, Streck, Dixion, Krish Biomedicals, ALCOR Scientific, Perlong Medical, Succeeder, Xilaiheng Medical Electronics, Pioway Medical, EASTMED Medical